✓ Last verified: April 7, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff

Known For: Numinus’s second Montreal location on Laurier West, providing ketamine-assisted psychotherapy and psychedelic-informed care in a warm, clinical setting in the heart of the Plateau.
| Google Reviews | Coming Soon |
| Location | Montreal, Quebec, Canada |
| Address | 397 Laurier West, Montreal, QC H2V 2K3 |
| Phone | +1 (514) 481-0317 |
| Website | numinus.com |
| Treatments | Ketamine-Assisted Psychotherapy (KAP), MDMA-Assisted Therapy, Psilocybin Therapy |
| Conditions | Depression, PTSD, Anxiety, Treatment-Resistant Depression, End-of-Life Distress |
| Cost | Contact for pricing |
| Insurance | Contact clinic for coverage details |
| KAP Available | Yes |
| Clinical Lead | Multidisciplinary Clinical Team |
HealingMaps Take: This second Numinus location in Montreal’s Plateau neighborhood offers the same high standard of psychedelic-assisted care that defines the Numinus brand. Having two nearby locations provides patients with scheduling flexibility while maintaining consistent clinical protocols.
Market Position: Numinus Laurier West treats both depression and PTSD — the two most common ketamine therapy indications, accounting for 34% of HealingMaps patient inquiries.
Industry pricing reference. Numinus Laurier West has not published specific per-session pricing — contact the clinic directly for a quote. The calculator above shows typical metro-level cost estimates across protocols, not this clinic’s specific prices.
| Protocol | Typical Industry Cost | Offered Here |
|---|---|---|
| IV Ketamine | $350–$650/session | — |
| Spravato (esketamine) | $0–$250 copay (insured) | — |
| IM Ketamine | $250–$400/injection | — |
| KAP (with therapist) | $400–$1,200/session | ✓ Yes |
| At-home troches | $150–$300/month | — |
Sources: CDC PLACES 2023 (, state-level prevalence) · U.S. Census ACS 5 Year · HealingMaps proprietary patient inquiry data.
Behind this data: HealingMaps has analyzed 23,496 patient inquiries (Oct 2022 – Mar 2026), mapped 1,473 verified clinics across 3,142 counties, scraped 132 clinic pricing pages, and collected 658 practitioner survey responses. This snapshot reflects our multi-source methodology.
13.5% of ketamine inquiries specifically cite PTSD — second only to depression as a driver of patient demand in the HealingMaps corpus. Source: HealingMaps 2026 Ketamine Clinic Intelligence Report — drawn from 23,496 patient inquiries and 132 clinic website analyses.
“The Numinus team created a safe, supportive space that allowed me to do deep therapeutic work. Their structured approach to preparation and integration was exactly what I needed.” — Patient Review
People struggling to overcome chronic and debilitating mood disorders with traditional medicine can finally find relief from their symptoms with ketamine therapy. The cutting-edge treatment option is available at Numinus Laurier West, one of three locations in Montreal. People living in the Montreal and surrounding areas can participate in solo ketamine infusion treatments or opt for group ketamine-assisted therapy for a more supportive session.
The knowledgeable and compassionate team at Numinus Laurier West understands that there is no one-size-fits-all treatment for mood disorders. Their patient-centered approach operates with that in mind, and they have multidisciplinary methods and tailored treatments to suit all their patients’ needs.
This 3-question summary is matched to the protocols and conditions Numinus Laurier West treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.
Yes — Numinus Laurier West offers KAP, which combines ketamine dosing with structured psychotherapy during the dissociative window. KAP sessions are longer than standalone infusions and priced accordingly. A reasonable consult question: whether KAP is delivered by a single integrated provider, or by a separate therapist working with the prescribing clinician.
Numinus Laurier West treats depression via KAP for trauma-anchored depression. Insurance coverage is rare for IV/KAP — most patients pay out of pocket. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.
Yes — Numinus Laurier West treats anxiety, including generalized anxiety, social anxiety, and panic disorder. The evidence base for ketamine in anxiety is less robust than for depression, but it can be a meaningful option for patients who haven’t responded to SSRIs or benzodiazepines. Worth asking which of their protocols they typically recommend for anxiety-primary patients.
Leave a Reply